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PLINICAL RESEARCH Interventional Cardiology
oor-to-Balloon Time With Primary
ercutaneous Coronary Intervention for Acute
yocardial Infarction Impacts Late Cardiac
ortality in High-Risk Patients and Patients
resenting Early After the Onset of Symptoms
ruce R. Brodie, MD, FACC,* Charles Hansen, MA,† Thomas D. Stuckey, MD, FACC,*
cott Richter, PHD,‡ Debra S. VerSteeg, RN,* Navin Gupta, MD, FACC,*
illiam E. Downey, MD, FACC,* Mark Pulsipher, MD, FACC*
reensboro, North Carolina
OBJECTIVES The purpose of this study was to evaluate the impact of door-to-balloon time with primary
percutaneous coronary intervention (PCI) on late cardiac mortality.
BACKGROUND The impact of door-to-balloon time on outcomes is controversial, and the impact on late
mortality has not been studied.
METHODS Consecutive patients (n  2,322) treated with primary PCI from 1984 to 2003 were
prospectively identified and followed up for a median of 83 months.
RESULTS Prolonged door-to-balloon times (0 to 1.4 h vs. 1.5 to 1.9 h vs. 2.0 to 2.9 h vs. 3.0 h) were
associated with higher in-hospital mortality (4.9% vs. 6.1% vs. 8.0% vs. 12.2%, p  0.0001)
and late mortality (12.6% vs. 16.4% vs. 20.4% vs. 27.1% at 7 years, p  0.0001) and were an
independent predictor of late mortality by Cox regression (p  0.0004). Prolonged
door-to-balloon times (2 h vs.2 h) were associated with higher late mortality in high-risk
patients (32.5% vs. 21.5%; hazard ratio [HR], 1.53; 95% confidence interval [CI], 1.22
to 1.90; p  0.0002) but not in low-risk patients (10.8% vs. 9.2%; HR, 1.13; 95% CI, 0.78
to 1.64; p  0.53) and in patients presenting early (3 h) (24.7% vs. 15.0%; HR, 1.54; 95%
CI, 1.24 to 1.90; p  0.0001) but not late (3 h) (21.1% vs. 18.5%; HR, 0.95; 95% CI, 0.62
to 1.45; p  0.80).
CONCLUSIONS Delays in door-to-balloon time impact late survival in high-risk but not low-risk patients and
in patients presenting early but not late after the onset of symptoms. These findings have
implications for the triage of patients for primary PCI. (J Am Coll Cardiol 2006;47:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.065289–95) © 2006 by the American College of Cardiology Foundation
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lrimary percutaneous coronary intervention (PCI) has been
hown to achieve superior outcomes compared with throm-
olytic therapy in the treatment of ST-segment elevation
cute myocardial infarction (STEMI) (1), and recent guide-
ines have recommended primary PCI as the preferred
eperfusion strategy when it can be performed by experi-
nced operators in a timely fashion (2). However, primary
CI is often not immediately available, and frequently there
re long treatment delays that could potentially impact
utcomes. The impact of treatment delays with primary
CI on outcomes has been controversial. Some studies have
hown that delays in door-to-balloon time adversely affect
utcomes (3,4), whereas other studies have found little
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esidency Program, Moses H. Cone Memorial Hospital, Greensboro, North Caro-
ina; and the ‡Department of Mathematics, University of North Carolina at
reensboro, Greensboro, North Carolina. This study was supported by grants from
he LeBauer Cardiovascular Research Foundation and the LeBauer Charitable
esearch Foundation, Greensboro, North Carolina.d
Manuscript received March 16, 2005; revised manuscript received August 9, 2005,
ccepted August 15, 2005.orrelation between door-to-balloon time and outcomes
5–7). None of these studies have evaluated the effect of
oor-to-balloon time on late cardiac mortality.
We postulated that the differences in the relationship
etween door-to-balloon time and mortality may be related
o differences in risk profile among studies. Consequently,
e examined the relationship between door-to-balloon time
nd late cardiac mortality in our large database with primary
CI with special attention to subgroup analyses in high-
nd low-risk patients.
ETHODS
tudy population. Our study population was taken from
,322 consecutive patients with STEMI treated with pri-
ary PCI without previous thrombolytic therapy at our
nstitution from 1984 through 2003. Patients with chest
ain of 12 h duration or 12 h for persistent pain or
emodynamic compromise and with electrocardiographic
T-segment elevation 1 mm in 2 contiguous leads or
eft bundle branch block and without severe co-morbid
isease were selected for intervention. After excluding 22
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Treatment Delays With Primary PCI January 17, 2006:289–95atients with missing door-to-balloon time data, our anal-
ses were performed on a study cohort of 2,300 patients.
reatment protocol. Patients were treated with heparin
nd aspirin in the emergency department and transferred
romptly to the catheterization laboratory for mechanical
eperfusion. Stents were first used in 1995 and overall were
sed in 30% of patients. Platelet glycoprotein IIb/IIIa
nhibitors were first used in 1996 and overall were used in
9% of patients. Ticlopidine or clopidogrel were used in
tent patients and continued for at least one month. Beta-
drenergic blocking agents and nitrates were used at the
perator’s discretion.
linical and angiographic follow-up. Clinical follow-up
as obtained by hospital and office chart review and
elephone contact in 97% of hospital survivors at a median
ollow-up time of 83 months. Follow-up catheterization
nd angiography were performed routinely during the first
hree years of the study and during participation in several
linical trials. Otherwise, follow-up catheterization was
erformed for recurrent ischemic symptoms or after abnor-
able 1. Baseline Clinical and Angiographic Variables by Door-t
0–1.4
(n  384)
linical variables
Age (yrs) 59.0  11.2
Age 70 yrs (%) 20.1
Women (%) 25.8
Diabetes mellitus (%) 11.5
Previous myocardial infarction (%) 19.5
Previous bypass surgery (%) 3.9
Anterior infarction (%) 31.3
Hypertension (%) 45.4
Current smoker (%) 49.3
Killip class 3–4 (%) 12.8
ngiographic variables
TIMI flow grade 2–3 before PCI (%) 19.8
TIMI flow grade 3 after PCI (%) 94.3
Three-vessel coronary artery disease (%) 20.8
Acute ejection fraction (%) 52.6  12.3
Abbreviations and Acronyms
CADILLAC  Controlled Abciximab and Device
Investigation to Lower Late Angioplasty
Complications
GUSTO  Global Utilization of Streptokinase and
Tissue Plasminogen Activator for
Occluded Coronary Arteries
NRMI  National Registry of Myocardial
Infarction
PAMI  Primary Angioplasty in Myocardial
Infarction
PCI  percutaneous coronary intervention
STEMI  ST-segment elevation myocardial
infarction
TIMI  Thrombolysis In Myocardial InfarctionCI  percutaneous coronary intervention; TIMI  Thrombolysis In Myocardial Infarctial functional test results. Follow-up catheterization pro-
edures with angiography adequate for measurement of left
entricular ejection fraction were obtained in 40% of hos-
ital survivors at a median follow-up time of 6.4 months.
efinitions and data analysis. Door-to-balloon time was
he time from arrival at the presenting hospital until balloon
nflation. Time to presentation was the time from symptom
nset until arrival at the presenting hospital. Patients were
lassified as diabetic if they had been treated with insulin or
ral hypoglycemic medication. Coronary flow in the infarct
rtery was assessed visually by the operator and classified
ccording to the Thrombolysis In Myocardial Infarction
TIMI) grading system on a scale of 0 to 3 (8). Reinfarction
as defined as recurrent chest pain associated with any
econdary increase in the creatinine kinase level and the MB
raction higher than the nadir, with or without diagnostic
lectrocardiographic changes. Urgent target vessel revascu-
arization was defined as the need for repeat PCI of the
arget vessel or bypass surgery for recurrent ischemia or
emodynamic compromise. High-risk patients were defined
s patients with Killip class 3 to 4, age70 years, or anterior
nfarction. Low-risk patients were all others.
Left ventricular ejection fractions were calculated from
racing the contours of right anterior oblique cine angio-
rams using the area-length method with correction for the
ight anterior oblique projection (9).
tatistical analysis. Statistical comparisons of categorical
ariables were performed using the chi-square test. Contin-
ous variables are presented as mean values (standard
eviation), and statistical comparisons were performed us-
ng analysis of variance. Predictors of in-hospital mortality
ere evaluated with multiple logistical regression. Differ-
nces in late cardiac survival across categories of treatment
imes were examined with Kaplan-Meier survival curves and
heir associated Wilcoxon statistics. Predictors of late car-
lloon Time
Door-to-Balloon Time (h)
.5–1.9
 493)
2.0–2.9
(n  750)
>3.0
(n  673) p Value
 12.4 60.5  12.2 60.4  12.8 0.01
20.9 24.5 26.3 0.05
29.8 29.6 34.2 0.03
12.8 14.5 18.3 0.009
16.0 18.8 13.5 0.02
3.4 5.5 5.6 0.22
40.0 37.6 41.8 0.007
47.4 47.9 49.2 0.69
48.2 46.9 45.4 0.63
14.4 14.3 23.9 0.0001
19.6 21.7 21.4 0.75
93.1 94.4 90.9 0.053
22.1 23.5 25.4 0.34
 12.3 50.7  12.9 48.8  13.1 0.0001o-Ba
1
(n
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January 17, 2006:289–95 Treatment Delays With Primary PCIiac mortality were performed using Cox proportional
azards regression models. Variables entered into the mod-
ls were age, gender, diabetes, prior infarction, prior bypass
urgery, anterior infarction, Killip class, hypertension,
moking status, and door-to-balloon time. All analyses were
erformed with SAS (SAS Institute Inc., Cary, North
arolina) and SPSS (SPSS Inc., Chicago, Illinois) software.
ESULTS
aseline variables by door-to-balloon time. The median
25th, 75th percentiles) door-to-balloon time was 2.3 h
1.6, 3.2) in all patients, 1.9 h (1.5, 2.5) in patients
resenting at the interventional hospital, and 2.9 h (2.3, 3.9)
n 871 patients transferred from non-interventional hospi-
als. Patients with longer door-to-balloon times were older,
ore often were women, and had a higher frequency of
iabetes, anterior infarction, and Killip class 3 to 4, but had
lower frequency of previous infarction (Table 1). Acute
jection fraction was lower in patients with longer door-to-
able 2. Baseline Clinical and Angiographic Variables in
igh- and Low-Risk Subgroups
Low Risk
(n  993)
High Risk*
(n  1,307) p Valu
linical variables
Age (yrs) 54.6  8.8 63.7  13.1 0.000
Age 70 yrs (%) 0 41.4 0.000
Women (%) 23.6 35.5 0.000
Diabetes mellitus (%) 12.1 16.8 0.002
Previous myocardial
infarction (%)
15.5 17.8 0.15
Previous bypass surgery (%) 4.6 5.0 0.71
Anterior infarction (%) 0 67.3 0.000
Hypertension (%) 45.7 49.3 0.09
Current smoker (%) 57.0 39.7 0.000
Killip class 3–4 (%) 0 29.7 0.000
ngiographic variables
TIMI flow grade 2–3
before PCI (%)
21.9 20.1 0.30
TIMI flow grade 3
after PCI (%)
95.4 91.4 0.000
Three-vessel coronary
artery disease (%)
19.9 25.9 0.000
Acute ejection fraction (%) 55.2  10.5 46.9  13.3 0.000
High-risk Killip class 3–4, age 70 years, or anterior infarction.
Abbreviations as in Table 2.
able 3. In-Hospital Outcomes by Door-to-Balloon Time
0–1.4
(n  384)
n-hospital outcomes
Mortality (%) 4.9
Reinfarction (%) 2.9
Stroke (%) 0.8
ardiac enzymes and ejection fraction
Peak creatinine kinase (U/l) 2,067  1,882 2,
Peak MB fraction (ng/ml) 170  170
Follow-up ejection fraction (%) 55.3  12.8 55.5 alloon times. A comparison of baseline variables in high-
isk versus low-risk patients as previously defined is shown
n Table 2.
n-hospital outcomes by door-to-balloon time. In-
ospital mortality was significantly higher with longer
oor-to-balloon times (Table 3). There were no significant
orrelations between door-to-balloon time and reinfarction
r stroke. Peak values of creatinine kinase and the MB
raction were significantly higher in patients with longer
oor-to-balloon times (Table 3).
After adjusting for differences in baseline variables, door-
o-balloon time was a significant independent predictor of
n-hospital mortality when expressed as a continuous vari-
ble (odds ratio [OR] 1.06; 95% confidence interval [CI],
.01 to 1.11; p  0.02) (OR expressed per 0.1 h) and as a
ategorical variable (compared with 0 to 1.4 h: 1.5 to 1.9 h,
R  1.34, 95% CI, 0.67 to 2.67; p  0.41; 2.0 to 2.9 h:
R  1.99; 95% CI, 1.07 to 3.69; p  0.03; 3.0 h: OR
2.38; 95% CI, 1.30 to 4.37; p  0.005).
ate cardiac mortality by door-to-balloon time. Pro-
onged door-to-balloon times (0 to 1.4 h vs. 1.5 to 1.9 h vs.
.0 to 2.9 h vs. 3.0 h) were associated with higher late
ortality (12.6% vs. 16.4% vs. 20.4% vs. 27.1% at 7 years,
 0.0001) with survival curves that diverged over time
Fig. 1). After adjusting for differences in baseline variables
ith Cox regression, door-to-balloon time was a significant
ndependent predictor of late cardiac mortality (Table 4).
oor-to-balloon time expressed as a continuous variable
as also a significant independent predictor of late cardiac
ortality (hazard ration [HR]  1.04; 95% CI, 1.01 to
.07; p  0.003) (HR expressed per 0.1 h).
ate cardiac mortality by door-to-balloon time in patient
ubgroups. The effects of door-to-balloon times on late
ardiac mortality in patient subgroups (with HRs adjusting
or differences in baseline variables) are shown in Table 5.
elays in door-to-balloon time (2 vs. 2 h) had a greater
mpact on late mortality in women versus men, anterior
ersus non-anterior infarction, Killip class 3 to 4 versus
illip class 1 to 2, early (3 h) versus late (3 h)
resentation, and high- versus low-risk patients. High-risk
atients were defined as patients with Killip class 3 to 4, age
70 years, or anterior infarction. There were trends or
ignificant interactions between door-to-balloon time and
Door-to-Balloon Time (h)
1.9
493)
2.0–2.9
(n  750)
>3.0
(n  673) p Value
1 8.0 12.2 0.0001
4 2.9 2.2 0.84
0 1.1 1.9 0.31
2,605 2,486  2,517 2,569  2,878 0.02
164 201  173 213  202 0.0021.5–
(n 
6.
2.
1.
436 
187 12.3 53.0  13.2 53.8  14.9 0.13
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Treatment Delays With Primary PCI January 17, 2006:289–95ach of the following variables: gender (p  0.06), infarct
ocation (p  0.13), Killip class (p  0.03), time to
resentation (p  0.16), and high- versus low-risk patients
p  0.02).
Kaplan-Meier unadjusted estimates of late cardiac sur-
ival show that prolonged door-to-balloon times (2 vs.2
) were associated with higher late mortality in high-risk
atients (32.5% vs. 21.5% at seven years; HR, 1.53; 95% CI,
.22 to 1.90; p  0.0002) but not in low-risk patients
10.8% vs. 9.2%; HR, 1.13; 95% CI, 0.78 to 1.64; p 0.53)
Table 5, Fig. 2). Survival curves also showed that prolonged
oor-to-balloon times (2 vs. 2 h) were associated with
igher late mortality in patients presenting early after the
nset of symptoms (3 h) (24.7% vs. 15.0% at seven years;
R, 1.54; 95% CI, 1.24 to 1.90; p  0.0001) but not late
fter the onset of symptoms (3 h) (21.1% vs. 18.5%; HR,
.95; 95% CI, 0.62 to 1.45; p  0.80) (Table 5, Fig. 3).
ISCUSSION
he major findings of this study are that delays in door-to-
alloon time with primary PCI for STEMI have a major
mpact on late cardiac mortality, and this impact is seen
rimarily in high-risk patients and patients who present
arly after the onset of symptoms.
revious studies. Previous studies have shown conflicting
esults regarding the importance of door-to-balloon time on
ortality (3–7). Door-to-balloon time was significantly
orrelated with in-hospital mortality in the Global Utiliza-
ion of Streptokinase and Tissue Plasminogen Activator for
ccluded Coronary Arteries (GUSTO)-IIb trial (3) and the
ational Registry of Myocardial Infarction (NRMI) (4).
he NRMI Investigators found that door-to-balloon times
igure 1. Kaplan-Meier estimates of late cardiac survival in patients
reated with primary percutaneous coronary intervention for ST-segment
levation myocardial infarction according to door-to-balloon times.2 h were associated with significantly increased mortality. Fonversely, data from the Stent Primary Angioplasty in
yocardial Infarction (PAMI) trial (5), the Zwolle Group
6), and the Controlled Abciximab and Device Investigation
o Lower Late Angioplasty Complications (CADILLAC)
rial (7) found no significant correlation between door-to-
alloon time and mortality (although the latter two trials did
how a significant correlation between overall time to
eperfusion and mortality). There may be several reasons for
hese differences. As documented in our study, delays in
oor-to-balloon time impact mortality primarily in high-
isk patients. Study cohorts with large numbers of low-risk
atients may not show a significant correlation between
oor-to-balloon time and mortality because of dilution of
he study cohort with low-risk patients. Secondly, sicker
atients may require additional procedures and additional
valuation (such as cardiopulmonary resuscitation, tempo-
ary pacemakers, intra-aortic balloon pumps, computed
omography scans, etc.), which create additional time delays
efore reperfusion. This potential bias for longer door-to-
alloon times in sicker patients would be more pronounced
n “real-world registries,” such as NRMI and our database,
han in randomized trials. This is exemplified in our study,
n which patients with the longest door-to-balloon times
ere older and had a much higher frequency of anterior
nfarction, diabetes, shock, and congestive heart failure.
hirdly, in large multicenter registries, door-to-balloon
ime may be a surrogate for quality of care. Finally, studies
hat look at short-term mortality would not appreciate the
ffect of treatment delays on long-term mortality.
mpact of treatment delays on mortality in subgroups. Our
tudy found that delays in door-to-balloon time had a major
mpact on late cardiac mortality in high-risk patients but
ad little effect in low-risk patients. Previous studies had not
valuated the relationship between door-to-balloon time
nd mortality in high- and low-risk patients, but several
tudies had found that total time to reperfusion (time from
ymptom onset to balloon inflation) correlated with mor-
ality in high-risk patients but not in low-risk patients
6,7,10,11).
We found that delays in door-to-balloon time had a
reater impact on late mortality in patients with Killip class
able 4. Multivariable Predictors of Late Cardiac Mortality by
ox Regression
Hazard Ratio
p Value(95% Confidence Interval)
illip class 3–4 3.03 (2.48–3.69) 0.0001
revious bypass surgery 2.15 (1.54–3.01) 0.0001
ge 70 yrs 1.93 (1.57–2.37) 0.0001
iabetes 1.75 (1.41–2.18) 0.0001
nterior infarction 1.49 (1.24–1.78) 0.0001
oor-to-balloon time (h)
1.5–1.9 1.17 (0.84–1.62) 0.36
2.0–2.9 1.46 (1.09–1.96) 0.01
3.0 1.71 (1.27–2.29) 0.0004
revious infarction 1.23 (0.99–1.54) 0.06
emale 1.19 (0.98–1.45) 0.08
3
i
n
t
i
m
s
s
t
p
i
P
t
b
b
a
b
u
b
t
t
i
i
d
t
u
C
i
F
m
p
T
A
A
F
M
D
N
A
N
K
K
E
L
H
L
* 70 y
293JACC Vol. 47, No. 2, 2006 Brodie et al.
January 17, 2006:289–95 Treatment Delays With Primary PCIto 4 versus 1 to 2, in anterior versus non-anterior
nfarction, in women versus men, and in diabetic versus
on-diabetic patients. We also found that delays in door-
o-balloon time were associated with increased late mortal-
ty in patients presenting early (3 h) but had little effect on
ortality in patients presenting late after the onset of
ymptoms (3 h). The CADILLAC investigators reported
imilar findings and found that delays in door-to-balloon
ime were associated with increased one-year mortality in
atients presenting early (2 h) but not in patients present-
ng late (2 h) (7).
aradigm for the mechanism of benefit of reperfusion
herapy. Our data suggesting that delays in door-to-
alloon time impact mortality in patients presenting early
igure 2. Kaplan-Meier estimates of late cardiac survival in patients treat
able 5. Late Cardiac Mortality by Door-to-Balloon Time in Pa
Late Cardiac M
Door-to-Balloon Time
<2 h (%)
D
ge  70 yrs (n  541) 28.4
ge 70 yrs (n  1,759) 12.4
emale (n  698) 18.0
ale (n  1,602) 14.6
iabetes (n  339) 24.0
o diabetes (n  1,961) 14.3
nterior infarction (n  880) 19.2
on-anterior infarction (n  1,420) 13.4
illip class 3–4 (n  388) 35.9
illip class 1–2 (n  1,912) 12.4
arly presentation (3 h) (n  1,767) 15.0
ate presentation (3 h) (n  533) 18.5
igh risk (n  1,307)† 21.5
ow risk (n  993) 9.2
Kaplan-Meier estimates at 7 years (median follow-up time). †Killip class 3–4, ageyocardial infarction according to door-to-balloon times. (A) High-risk patient
atients.ut not late after the onset of symptoms are consistent with
n expanded paradigm for the mechanism of mortality
enefit with reperfusion therapy (12). In patients who
ndergo reperfusion therapy early, the mortality benefit may
e related primarily to myocardial salvage, and this is very
ime dependent. In patients who undergo reperfusion later,
he mortality benefit may be related to the effect of an open
nfarct artery in preventing left ventricular remodeling and
n promoting electrical stability, and this is not very time
ependent. Previous and recent studies have documented
hat to achieve significant myocardial salvage, reperfusion
sually must be established at 2 to 3 h (13,14).
linical implications. Our study has implications regard-
ng the triage of patients with STEMI presenting at
th primary percutaneous coronary intervention for ST-segment elevation
Subsets
lity*
Hazard Ratio
95% Confidence
Interval p Value
to-Balloon Time
>2 h (%)
41.7 1.44 1.05–1.98 0.02
17.9 1.37 1.08–1.73 0.01
29.8 1.79 1.29–2.49 0.0005
20.9 1.23 0.97–1.56 0.09
40.7 1.72 1.12–2.62 0.01
20.5 1.33 1.08–1.65 0.008
31.0 1.62 1.23–2.12 0.0005
19.1 1.18 0.91–1.54 0.22
58.3 1.78 1.25–2.53 0.001
15.7 1.22 0.97–1.54 0.09
24.7 1.54 1.24–1.90 0.0001
21.1 0.95 0.62–1.45 0.80
32.5 1.53 1.22–1.90 0.0002
10.8 1.13 0.78–1.64 0.53
ears, or anterior infarction.ed witient
orta
oor-s (Killip class 3 to 4, age 70 years, or anterior infarction). (B) Low-risk
n
d
p
h
p
a
d
t
r
t
t
p
m
l
a
r
n
T
i
b
P
l
a
o
r
S
h
o
e
t
b
d
t
t
b
c
S
s
a
a
a
m
A
a
r
H
b
1
a
t
b
a
t
R
N
2
R
F
a e on
s
294 Brodie et al. JACC Vol. 47, No. 2, 2006
Treatment Delays With Primary PCI January 17, 2006:289–95on-interventional hospitals. The results from recent ran-
omized trials have found that outcomes are better when
atients with STEMI who present at non-interventional
ospitals are transferred to an interventional facility for
rimary PCI compared with being given fibrinolytic therapy
t the local hospital (15–17). The additional treatment
elays of primary PCI compared with fibrinolytic therapy in
hese trials ranged from 55 to 104 min. The optimum
eperfusion strategy when delays to primary PCI are longer
han this has not been evaluated.
Our data indicate that in patients who present early after
he onset of symptoms, delays in door-to-balloon times with
rimary PCI seem to have a significant impact on late
ortality. If these delays are long enough, primary PCI may
ose its mortality advantage over fibrinolytic therapy. (The
dvantage of primary PCI over fibrinolytic therapy in
educing reinfarction with fewer complications of intracra-
ial hemorrhage and stroke may be less time dependent.)
he optimum reperfusion strategy in these patients may
nclude alternative reperfusion strategies such as local fi-
rinolytic therapy or combined pharmacologic therapy and
CI (facilitated PCI). In contrast, in patients who present
ater, treatment delays have much less effect on mortality,
nd transfer for primary PCI may be the best reperfusion
ption, even with longer delays. The results of large ongoing
andomized trials of facilitated PCI in patients with
TEMI presenting to non-interventional hospitals should
elp define the optimum reperfusion strategies in subgroups
f patients who have long treatment delays to primary PCI.
Door-to-balloon times in this study are quite long,
specially for patients transferred from community hospitals
o our institution. Similarly long door-to-balloon times have
een recently reported from the NRMI (18). Although
oor-to-balloon times have improved some at our institu-
igure 3. Kaplan-Meier estimates of late cardiac survival after primary perc
ccording to door-to-balloon times. (A) Patients presenting early after th
ymptoms (3 h).ion in recent years, the prolonged delays in this study andhe NRMI emphasize the need in this country to develop
etter protocols for the triage and transfer of patients from
ommunity hospitals to interventional facilities.
tudy limitations. This is a single-center observational
tudy, and there may be differences in baseline variables
cross categories of door-to-balloon times that may not be
ccounted for in the multivariable analyses and that may
ffect the relationship between door-to-balloon time and
ortality. Our study spans two decades of experience.
lthough this allows for long-term follow-up, changes in
djunctive therapies with primary PCI could impact the
elationship between door-to-balloon time and outcomes.
owever, we examined the relationship between door-to-
alloon time and late mortality in the period before (1984 to
995) and after (1996 to 2003) the introduction of stents
nd glycoprotein IIb/IIIa platelet inhibitors and the rela-
ionships were similar. Finally, reperfusion may occur before
alloon inflation, either spontaneously or as the result of the
dministration of heparin and aspirin, and in these patients
he time to reperfusion is unknown.
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